Site Map

Biometrics »

Contact Lens Wear Improves How Children And Teens Feel About Their Appearance, Participation In Activities, Clinical Study Shows

Sun, 18 Nov 2007 Similar Items Print Press Release Submissions »

Compared to glasses, contact lens wear significantly improves how children and teenagers feel about their appearance and participation in activities a newly published study shows. These quality of lif… Read »

 

Similar Items:
Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg And Back PainStudy Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg And Back Pain
Oral Anticancer Drug CP-4126 Enters Clinical Phase I StudyOral Anticancer Drug CP-4126 Enters Clinical Phase I Study
Early Data Show Potential For Imatinib To Treat Life-threatening Form Of Pulmonary Artery DiseaseEarly Data Show Potential For Imatinib To Treat Life-threatening Form Of Pulmonary Artery Disease
Unisys Research Shows Majority Of Consumers Worldwide Trust Biometrics For Data ProtectionUnisys Research Shows Majority Of Consumers Worldwide Trust Biometrics For Data Protection
Pivotal Phase Iii Study Shows Mabthera Delays Disease Progression In Patients With Relapsed Or Refractory Chronic Lymphocytic LeukaemiaPivotal Phase Iii Study Shows Mabthera Delays Disease Progression In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukaemia
Roche Announces Topline Outcomes For Avastin-tarceva Combination Study In Advanced Lung CancerRoche Announces Topline Outcomes For Avastin-tarceva Combination Study In Advanced Lung Cancer
Nexavar Significantly Improves Overall Survival By 47 Percent In Asia-pacific Liver Cancer StudyNexavar Significantly Improves Overall Survival By 47 Percent In Asia-pacific Liver Cancer Study
Genzyme Begins Enrollment In Post-marketing Study To Evaluate Use Of Low Dose Fabrazyme Treatment For Fabry DiseaseGenzyme Begins Enrollment In Post-marketing Study To Evaluate Use Of Low Dose Fabrazyme Treatment For Fabry Disease
BAYER’S Xarelto® Shows Encouraging Results In Patients With Acute Coronary SyndromeBAYER’S Xarelto® Shows Encouraging Results In Patients With Acute Coronary Syndrome
Researchers To Evaluate A Once-daily Investigational Dose Of Raltegravir, MERCK’S Integrase Inhibitor, In An Investigational Population, Patients Previously Untreated For HIV-1Researchers To Evaluate A Once-daily Investigational Dose Of Raltegravir, MERCK’S Integrase Inhibitor, In An Investigational Population, Patients Previously Untreated For HIV-1